Duox2 Modulation of Viral Infection in Airway Epithelium
Duox2 调节气道上皮病毒感染
基本信息
- 批准号:7758765
- 负责人:
- 金额:$ 30.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-02-01 至 2013-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAcuteAddressAntiviral AgentsAntiviral ResponseApicalAsthmaBiometryCenter for Translational Science ActivitiesClinicalConsultCritiquesEpithelial CellsEpitheliumEventGenerationsGenesHeadHealth SciencesHost DefenseHourHumanHydrogen PeroxideInfectionInterleukin-13Interleukin-4KnowledgeLungMediatingModelingPatientsPrincipal InvestigatorProductionProteinsPublic HealthReactive Nitrogen SpeciesRespiratory SystemRespiratory tract structureRhinovirusServicesSignal PathwaySystemTestingTimeUp-RegulationViralVirus DiseasesW7 (Calmodulin Antagonist)airway epitheliumasthmatic patientcytokinenovelpathogenprofessorprograms
项目摘要
DESCRIPTION (provided by applicant): Rhinovirus (RV) is an important pathogen present in the respiratory tract epithelium of a significant proportion of asthma patients during severe pulmonary exacerbations. Mechanisms by which the human respiratory tract epithelium identifies acute RV infection, mechanisms used immediately by the human respiratory tract epithelium to respond to this infection, and how these mechanisms are impaired in asthmatics have not been fully elucidated. Our recent studies of DUOX2 suggest this protein is critical for normal antiviral host defense. We hypothesize that DUOX2 is a central component for host defense against RV infection in respiratory tract epithelium: When activated by RV, DUOX2 produces hydrogen peroxide (H2O2), hypohalous acid, or reactive nitrogen species to (a) directly inactivate rhinovirus and (b) stimulate the expression of early antiviral genes, but (c) antiviral activity is suppressed in the presence of Th2 cytokines such as interleukin-4 (IL- 4) or interleukin-13 (IL-13). Specific Aims: Test the predictions that (1) DUOX2-mediated generation of H2O2, hypohalous acids, or reactive nitrogen species directly inactivates RV, (2) DUOX2- mediated generation of H2O2 results in the early activation of antiviral genes, and (3) IL-4 blocks DUOX2-mediated antiviral activity by inhibiting transcriptionally-mediated DUOX2 expression. We will use human respiratory tract epithelial cells for all the studies outlined for this project. Relevance to Public Health - Rhinovirus (RV) is an important pathogen present in the respiratory tract epithelium of a significant proportion of asthma patients during severe pulmonary exacerbations. Our recent studies of DUOX2 suggest this protein is critical for normal antiviral host defense. We anticipate our studies will reveal novel mechanisms by which the respiratory tract epithelium activates innate host defense against RV infection. These studies will potentially elucidate specific mechanisms that are impaired in asthmatic patients.
描述(申请人提供):鼻病毒(RV)是一种重要的病原体,存在于相当大比例的哮喘患者的严重肺加重期间的呼吸道上皮中。人类呼吸道上皮细胞识别急性轮状病毒感染的机制,人类呼吸道上皮细胞立即用来应对这种感染的机制,以及这些机制在哮喘患者中是如何受损的,还没有完全阐明。我们最近对DUOX2的研究表明,该蛋白对正常的抗病毒宿主防御至关重要。我们假设DUOX2是宿主抵抗呼吸道上皮RV感染的中心成分:当被RV激活时,DUOX2产生过氧化氢(H2O2)、次卤酸或反应性氮物种,以(A)直接灭活鼻病毒,(B)刺激早期抗病毒基因的表达,但(C)抗病毒活性在Th2细胞因子如白介素4(IL-4)或白介素13(IL-13)的存在下被抑制。具体目的:验证以下预测:(1)DUOX2介导的过氧化氢、次卤酸或活性氮物种的产生直接灭活轮状病毒,(2)DUOX2介导的过氧化氢产生导致抗病毒基因的早期激活,以及(3)IL-4通过抑制转录介导的DUOX2表达来阻断DUOX2介导的抗病毒活性。我们将使用人类呼吸道上皮细胞进行这个项目概述的所有研究。与公共卫生相关-鼻病毒(RV)是一种重要的病原体,存在于相当大比例的哮喘患者的严重肺加重期间的呼吸道上皮中。我们最近对DUOX2的研究表明,该蛋白对正常的抗病毒宿主防御至关重要。我们预计我们的研究将揭示呼吸道上皮激活针对轮状病毒感染的天然宿主防御的新机制。这些研究可能会阐明哮喘患者受损的具体机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richart W Harper其他文献
Richart W Harper的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richart W Harper', 18)}}的其他基金
Defining Breath VOC Biomarkers to Improve Respiratory Health of Exposed Veterans
定义呼吸 VOC 生物标志物以改善接触过的退伍军人的呼吸健康
- 批准号:
10015032 - 财政年份:2021
- 资助金额:
$ 30.4万 - 项目类别:
Defining Breath VOC Biomarkers to Improve Respiratory Health of Exposed Veterans
定义呼吸 VOC 生物标志物以改善接触过的退伍军人的呼吸健康
- 批准号:
10553150 - 财政年份:2021
- 资助金额:
$ 30.4万 - 项目类别:
Defining Breath VOC Biomarkers to Improve Respiratory Health of Exposed Veterans
定义呼吸 VOC 生物标志物以改善接触过的退伍军人的呼吸健康
- 批准号:
10355416 - 财政年份:2021
- 资助金额:
$ 30.4万 - 项目类别:
Duox2 Modulation of Viral Infection in Airway Epithelium
Duox2 调节气道上皮病毒感染
- 批准号:
7837499 - 财政年份:2009
- 资助金额:
$ 30.4万 - 项目类别:
Duox2 Modulation of Viral Infection in Airway Epithelium
Duox2 调节气道上皮病毒感染
- 批准号:
7370003 - 财政年份:2008
- 资助金额:
$ 30.4万 - 项目类别:
Duox2 Modulation of Viral Infection in Airway Epithelium
Duox2 调节气道上皮病毒感染
- 批准号:
7561050 - 财政年份:2008
- 资助金额:
$ 30.4万 - 项目类别:
Duox2 Modulation of Viral Infection in Airway Epithelium
Duox2 调节气道上皮病毒感染
- 批准号:
8215722 - 财政年份:2008
- 资助金额:
$ 30.4万 - 项目类别:
Thioredoxin localization and its function in the airway
硫氧还蛋白定位及其在气道中的功能
- 批准号:
6933806 - 财政年份:2001
- 资助金额:
$ 30.4万 - 项目类别:
Thioredoxin localization and its function in the airway
硫氧还蛋白定位及其在气道中的功能
- 批准号:
6653908 - 财政年份:2001
- 资助金额:
$ 30.4万 - 项目类别:
Thioredoxin localization and its function in the airway
硫氧还蛋白定位及其在气道中的功能
- 批准号:
6327134 - 财政年份:2001
- 资助金额:
$ 30.4万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 30.4万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 30.4万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 30.4万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 30.4万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 30.4万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 30.4万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 30.4万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 30.4万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 30.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 30.4万 - 项目类别:
Standard Grant